Veterinary Medicines

LINEOMAM LC, Intramammary solution

Authorised
  • Lincomycin
  • NEOMYCIN SULFATE
Download as PDF

Product identification

Medicine name:
LINEOMAM LC, Intramammary solution
LINEOMAM LC, 330 mg/10 mL + 100000 i.j./10 mL, intramamarna otopina
Active substance:
  • Lincomycin
  • NEOMYCIN SULFATE
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Lincomycin
    330.00
    milligram(s)
    /
    1.00
    Applicator
  • NEOMYCIN SULFATE
    100000.00
    international unit(s)
    /
    1.00
    Applicator
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        3
        day
      • Milk
        84
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RF03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/21-01/130
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0138/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 10/05/2023
Download